Detalhe da pesquisa
1.
Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial.
Am J Transplant
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467375
2.
Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.
Am J Transplant
; 22(9): 2169-2179, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634722
3.
Improvements in Disease-Specific Health-Related Quality of Life of Pediatric Liver Transplant Recipients During Immunosuppression Withdrawal.
Liver Transpl
; 27(5): 735-746, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33280227
4.
Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.
Am J Transplant
; 19(5): 1545-1551, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30614623
5.
Hospital readmission following pediatric heart transplantation.
Pediatr Transplant
; 23(7): e13561, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483086
6.
Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation.
Am J Transplant
; 18(9): 2135-2147, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446208
7.
Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: A multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04).
J Heart Lung Transplant
; 38(9): 972-981, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324444